University of Wisconsin–Madison Medical College of Wisconsin


The Wisconsin Medical Journal is seeking candidates to serve as Deputy Editor.

Read more

Volume 121, Issue 4 (December 2022)


Snowmobiling is a popular winter activity in Wisconsin and also a source of injury. Unfortunately, due to the rural location and procedure for reporting snowmobile-related injuries, assessing the magnitude of the problem is challenging. A study in this issue of WMJ sought to accurately calculate the incidence and severity of these injuries over a 5-year period.





All articles published in WMJ, including commentaries, letters to the editor, and editorials represent the views of the authors, for which neither WMJ nor the publisher takes responsibility, unless clearly stated.

call4papers-postCOVIDCall for Papers

The Wisconsin Medical Journal is seeking papers for a special issue examining lessons learned from the COVID-19 pandemic and its aftermath.

Read More

Featured Content

Detailed information about current, cutting-edge topics in the pharmacy world.

Read More

Vol. 120, Suppl 1: A Special Issue on the Impact of Race and Racism on Health

Read More

A repository of COVID-19-related content published in WMJ

Read More

About WMJ

WMJ—the Wisconsin Medical Journal—is a peer-reviewed, indexed, scientific journal published quarterly and online ahead of print each month through a collaboration between the Medical College of Wisconsin and the University of Wisconsin School of Medicine and Public Health.


MCW logo

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) and the Wisconsin Medical Journal. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

#Auvelity (dextromethorphan/bupropion)
was approved by the #FDA for the treatment of major depressive disorder in adults on August 19, 2022. Learn more about it in our latest #Pharmacotherapy Update: @MCWPharmacy @FA_Nephrology

A look at 5-year trends in snowmobile-related injuries in rural Wisconsin is among the studies published in the latest issue of #WMJonline. #snowmobile #ruralhealth @FA_Nephrology @MCResearchInst

Load More